Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page
- Check3 days agoChange DetectedThe page has updated the status of a clinical trial to 'Unknown' and revised the version number from v2.16.4 to v2.16.5.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check81 days agoChange DetectedThe page has undergone significant content changes regarding the treatment of newly diagnosed Multiple Myeloma patients, particularly focusing on the efficacy of Daratumumab in combination therapies. Key details about the AMN006 study and its inclusion and exclusion criteria have been added, while substantial information about previous treatment outcomes and the need for new therapies has been removed.SummaryDifference46%
Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.